These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15818515)

  • 21. Depression measures and motor side-effects in patients with acute schizophrenia.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Margariti MM; Kollias CT; Christodoulou GN
    Schizophr Res; 2002 Jul; 56(1-2):197-8. PubMed ID: 12084435
    [No Abstract]   [Full Text] [Related]  

  • 22. Extrapyramidal motor abnormalities associated with late-life psychosis.
    Caligiuri MP; Lohr JB; Panton D; Harris MJ
    Schizophr Bull; 1993; 19(4):747-54. PubMed ID: 7905662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
    Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
    Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metaclopramide neurotoxicity.
    Santos A; Arana G
    J S C Med Assoc; 1988 Nov; 84(11):542-5. PubMed ID: 3059051
    [No Abstract]   [Full Text] [Related]  

  • 27. An interview with Jeffrey A. Lieberman: Tardive Dyskinesia. [interview by Sussman Norman].
    Lieberman JA
    CNS Spectr; 2007 Oct; 12(10):747-50. PubMed ID: 18018327
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute dystonic reactions complicated by psychotic phenomena.
    Thornton A; McKenna PJ
    Br J Psychiatry; 1994 Jan; 164(1):115-8. PubMed ID: 7802754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orofacial movement disorders.
    Balasubramaniam R; Ram S
    Oral Maxillofac Surg Clin North Am; 2008 May; 20(2):273-85, vii. PubMed ID: 18343330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychopathology in never-treated schizophrenia.
    Tirupati SN; Padmavati R; Thara R; McCreadie RG
    Compr Psychiatry; 2006; 47(1):1-6. PubMed ID: 16324896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenothiazine-induced decompensation.
    Van Putten T; Mutalipassi LR; Malkin MD
    Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
    [No Abstract]   [Full Text] [Related]  

  • 34. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia.
    Müller M
    Schizophr Res; 2002 Oct; 57(2-3):307. PubMed ID: 12223263
    [No Abstract]   [Full Text] [Related]  

  • 36. Gait disturbances in patients with schizophrenia and adaptation to treadmill walking.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):303-10. PubMed ID: 15896224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The basal ganglia and cognitive pattern generators.
    Graybiel AM
    Schizophr Bull; 1997; 23(3):459-69. PubMed ID: 9327509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.